Chronic Disease
Chronic Disease
Modeling Health
Approximately half of all U.S. adults suffer from at least one chronic condition. Schaeffer Scholars are modeling the value of treatments and interventions that will reduce this burden.
Related Topics
Top Stories View All
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
Featured Experts: Alison Sexton Ward, Erin Trish, Dana Goldman, Darius Lakdawalla
In The News View All
STAT
Expanded coverage of GLP-1s is “probably the single most effective policy” for improving public health, Goldman says
Featured Experts: Dana Goldman
KFF Heath News
Sood explains why many states capped insulin costs
Featured Experts: Neeraj Sood
KFF Health News
Ward discusses modeling the benefits of anti-obesity medications
Featured Experts: Alison Sexton Ward
STAT
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
Featured Experts: Dana Goldman, Alison Sexton Ward
The Washington Post
Goldman predicts insurers will soon be able to negotiate deeper discounts on GLP-1s
Featured Experts: Dana Goldman
Featured Testimony
Testimony on Incentivizing Chronic Disease Prevention and Treatment
Rebalancing the healthcare system to favor prevention and cures can potentially reduce the long-term burden of chronic diseases.
Experts: Anne Peters
Featured Article
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Experts: Dana Goldman, Bryan Tysinger
